Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Animal Models for Coffin-Lowry Syndrome: RSK2 and Nervous System Dysfunction.
|
29875643 |
2018 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Here we report the first in-frame deletion in C-terminal KD of RPS6KA3 in a CLS patient with drop episodes.
|
25044551 |
2014 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
How RSK2-deficiency leads to cognitive dysfunctions in CLS is however poorly understood.
|
29627578 |
2018 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Three candidate genes in this region were investigated: the cDNA for kinase Rsk-2 involved in Coffin-Lowry syndrome, the brain-specific exon of a transcript in the DMD locus (DP140 isoform of dystrophin), and exon 18 of the glycerol kinase gene, which is specific to fetal brain transcripts.All three sequences were normal.
|
10190484 |
1999 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
We examined, using X-Ray microtomographic analysis, the variable craniofacial dysmorphism and dental anomalies present in Rsk2 knockout mice, a model of Coffin-Lowry syndrome, as well as in triple Rsk1,2,3 knockout mutants.
|
24416220 |
2014 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Rsk2, the Kinase Mutated in Coffin-Lowry Syndrome, Controls Cementum Formation.
|
26927527 |
2016 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Thus, Rsk2 loss-of-function, as seen in CLS, perturbs the differentiation of neural precursors into neurons, and maintains them instead as proliferating radial precursor cells, a defect that may underlie the cognitive dysfunction seen in CLS.
|
20832397 |
2010 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
|
12765942 |
2003 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
This microduplication is only the third intragenic duplication of RPS6KA3, and the second and smallest reported to date thought to cause CLS.
|
31512387 |
2019 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We have identified a Coffin-Lowry syndrome pedigree where the disorder is associated with a novel splice site mutation in the RSK2 gene, leading to in-phase skipping of exon 5.
|
9887375 |
1999 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
We have tested five unrelated individuals with CLS for mutations in nine exons of Rsk-2 using Single Strand Conformation Polymorphism (SSCP) analysis.
|
10094187 |
1999 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Here we report on a 2-year-old boy with Coffin-Lowry syndrome with a novel missense mutation in the RPS6KA3 gene.
|
29678278 |
2018 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the RSK2 gene (RPS6KA3) on chromosome Xp22.2, have been found to cause Coffin-Lowry syndrome (CLS), an X-linked disorder characterized by psychomotor retardation, characteristic facial and digital abnormalities, and progressive skeletal deformations.
|
11180593 |
2001 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The map intervals of 5 X-linked mental retardation loci, MRX2 (Xp22.1-p22.2), MRX19 (Xp22), MRX21 (Xp21.1-p22.3), MRX29 (Xp21.2-p22.1), and MRX32 (Xp21.2-p22.1), and two syndromal mental retardation loci, Partington syndrome (PRTS; Xp22) and Coffin-Lowry syndrome (CLS; Xp22.13-p22.2), overlap this region.
|
8826457 |
1996 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
CLS is caused by mutations in a gene located in Xp22.2 and encoding RSK2, a growth-factor regulated protein kinase.
|
11896450 |
2002 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The first large duplication of the RSK2 gene identified in a Coffin-Lowry syndrome patient.
|
17717706 |
2007 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Here we present 44 novel mutations in RSK2 causing CLS.
|
16879200 |
2006 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Initial screening for mutations in the gene for Rsk-2 in 76 unrelated CLS patients revealed one intragenic deletion, a nonsense, two splice site, and two missense mutations.
|
8955270 |
1996 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
CLS is caused by mutations in a gene located in Xp22.2 and encoding RSK2, a growth-factor regulated protein kinase.
|
11896450 |
2002 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Delineation of the mechanisms of aberrant splicing caused by two unusual intronic mutations in the RSK2 gene involved in Coffin-Lowry syndrome.
|
14973203 |
2004 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Initial screening for mutations in the gene for Rsk-2 in 76 unrelated CLS patients revealed one intragenic deletion, a nonsense, two splice site, and two missense mutations.
|
8955270 |
1996 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome.
|
14986828 |
2003 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
In the present report, a male patient affected with Coffin-Lowry syndrome is shown to have a nonsense mutation of the RSK2 gene.
|
11746134 |
2001 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome.
|
14986828 |
2003 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A novel RSK2 (RPS6KA3) gene mutation associated with abnormal brain MRI findings in a family with Coffin-Lowry syndrome.
|
16691578 |
2006 |